BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND Ki-67
1656 results:

  • 1. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.
    Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
    Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic utility and characteristics of MIB-1 labeling index as a proliferative activity marker in childhood low-grade glioma: a retrospective observational study.
    Gorodezki D; Zipfel J; Bevot A; Nägele T; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):178. PubMed ID: 38580878
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The association between calreticulin and glucagon-like peptide-1 expressions with prognostic factors in high-grade gliomas.
    Baran O; Akgun MY; Kayhan A; Evran S; Ozbek A; Akyoldas G; Samanci MY; Demirel N; Sonmez D; Serin H; Kocak A; Kemerdere R; Tanriverdi T
    J Cancer Res Ther; 2024 Jan; 20(1):25-32. PubMed ID: 38554294
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Post molar choriocarcinoma with solitary renal metastasis in the absence of primary uterine tumor: a case report and review of the literature.
    Geravandi M; Hajihashemi A; Adibi A; Habibi Tirtashi R
    J Med Case Rep; 2024 Mar; 18(1):132. PubMed ID: 38553733
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Generative adversarial network-based synthesis of contrast-enhanced MR images from precontrast images for predicting histological characteristics in breast cancer.
    Fan M; Cao X; Lü F; Xie S; Yu Z; Chen Y; Lü Z; Li L
    Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537294
    [No Abstract]    [Full Text] [Related]  

  • 8. Enhanced clinical outcomes with radiotherapy in diagnostically challenging intracranial plasmacytomas: Analysis of 190 cases.
    Feng Y; Zhang Z; Qiu F; Yang Z; Xiong J; Zhu W; Wan F; Chen B; Wang J; Zhang Y; Hua W
    Cancer Med; 2024 Feb; 13(4):e7017. PubMed ID: 38457205
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole-tumor histogram analysis of postcontrast T1-weighted and apparent diffusion coefficient in predicting the grade and proliferative activity of adult intracranial ependymomas.
    Liu X; Han T; Wang Y; Liu H; Sun Q; Xue C; Deng J; Li S; Zhou J
    Neuroradiology; 2024 Apr; 66(4):531-541. PubMed ID: 38400953
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological analysis of rosette-forming glioneuronal tumors.
    Liu J; Lin F; Sun Y; Liu X
    Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A rare case of benign metastasizing leiomyoma at vertebrae.
    Kachhwaha A; Bharti JN; Solanki A; Soni S; Pareek P
    J Cancer Res Ther; 2023 Oct; 19(7):2072-2075. PubMed ID: 38376323
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
    Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
    Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Construction of brain metastasis prediction model in limited stage small cell lung cancer patients without prophylactic cranial irradiation.
    Guo J; Liu J; Ye W; Xu J; Zhong W; Zhang X; Yuan H; Shi H; Li T; Xu Y; Mao J; Shen B; Wu D
    Clin Respir J; 2024 Jan; 18(1):e13730. PubMed ID: 38286746
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
    Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
    Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
    Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
    BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
    Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
    Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review.
    Maroufi SF; Doğruel Y; Pour-Rashidi A; Kohli GS; Parker CT; Uchida T; Asfour MZ; Martin C; Nizzola M; De Bonis A; Tawfik-Helika M; Tavallai A; Cohen-Gadol AA; Palmisciano P
    Pituitary; 2024 Apr; 27(2):91-128. PubMed ID: 38183582
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A novel grading system combining histological grade and CDKN2A homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma.
    Xi S; Huang Q; Zeng J
    J Neuropathol Exp Neurol; 2024 Jan; 83(2):125-130. PubMed ID: 38175671
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.
    Kim GR; Kang JH; Kim HJ; Im E; Bae J; Kwon WS; Rha SY; Chung HC; Cho EY; Kim SY; Kim YC
    Bioorg Chem; 2024 Feb; 143():107061. PubMed ID: 38154386
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.
    Ren L; Chen J; Deng J; Qing X; Cheng H; Wang D; Ji J; Chen H; Juratli TA; Wakimoto H; Gong Y; Hua L
    J Neurooncol; 2024 Jan; 166(1):59-71. PubMed ID: 38146046
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 83.